Proteomics research of gallblader cancer cell line treatment with thalidomide
Author:
Affiliation:

Clc Number:

R 735.8

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To study the relevant differential expression proteins of GBC-SD cell line after treatment with thalidomide and the molecular mechanism.
    Methods:Proteomic techniques and methods were used to separate the  differential expression proteins in GBC-SD cells after treated wiht that idomide (experiment group) and control group.
    Results:The  differential expression proteins in experiment group and control group, whose spots variance was over 2-fold, were analysed  with PDQuest software,and found out 36 protein spots at difference level of expression(P<0.05), including 13 spots decreasing and 23 spots increasing  in experiment group. Then, 10 spots with more than 3-fold difference of  expression level were selected for anslysis, and 7 protein spots were identified.
    Conclusions:Thalidomide has some effect on GBC-SD cells. Study on the function of differential protein can be as a basis for research on the mechanism of thalidomide treatment of gallbladder cancer.

    Reference
    Related
    Cited by
Get Citation

ZHU Guomin, ZHONG Dewu, LI Xueming, LIU Xiping. Proteomics research of gallblader cancer cell line treatment with thalidomide[J]. Chin J Gen Surg,2011,20(2):159-162.
DOI:10.7659/j. issn.1005-6947.2011.02.013

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 21,2010
  • Revised:January 22,2011
  • Adopted:
  • Online: February 15,2011
  • Published: